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Abstract: Ambulatory electrocardiography (AECG) is a primary diagnostic tool in patients with
potential arrhythmic disorders. To study the pathophysiological mechanisms of arrhythmic disorders,
mouse models are widely implemented. The use of a technique similar to AECG for mice is thus
of great relevance. We have optimized a protocol which allows qualitative, long-term ECG data
recording in conscious, freely moving mice. Automated algorithms were developed to efficiently
process the large amount of data and calculate the average heart rate (HR), the mean peak-to-peak
interval and heart rate variability (HRV) based on peak detection. Ectopic beats are automatically
detected based on aberrant peak intervals. As we have incorporated a multiple lead configuration
in our ECG set-up, the nature and origin of the suggested ectopic beats can be analyzed in detail.
The protocol and analysis tools presented here are promising tools for studies which require detailed,
long-term ECG characterization in mouse models with potential arrhythmic disorders.
Keywords: ambulatory electrocardiography; mouse; peak analysis; tethered ECG
1. Introduction
Cardiovascular disease (CVD) is the leading cause of death worldwide [1,2]. A combination of
high mortality and morbidity rates has been attributed to common CVDs including coronary artery
disease, stroke, heart failure, and arrhythmias, making early detection and treatment of these CVDs
imperative [1,2]. One of the most important screening tools for CVD is the resting electrocardiogram
(ECG). The obtained signal on an ECG represents a series of heartbeats each consisting of multiple
different deflections of the electrical tracing. These include the P-wave (depolarization of the atria), the
QRS-complex (depolarization of the ventricles) and the T-wave (repolarization of the ventricles) [3,4].
A trained physician can utilize the ECG to assess many aspects, including the heart rate and rhythm,
conduction abnormalities and myocardial disease [3,4]. Despite its many advantages, a common
limitation of an ECG is its duration. A standard ECG registers cardiac signals during a short period
of 10 s. Transient conditions such as arrhythmias or conduction problems may therefore remain
undetected [3,4].
Ambulatory (or continuous) ECG (AECG) measurement overcomes the temporal limitations of
the standard ECG by extending the diagnostic capabilities over a prolonged period of time, typically
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24 h or 48 h [5]. This extended monitoring period is associated with an improved diagnostic yield [5].
The European Society of Cardiology guidelines suggest that patients who have arrhythmia-related
symptoms should receive a 24-h ambulatory ECG, in order to detect potential detrimental ventricular
arrhythmia and conduction disorders and preventing SCD [6,7]. The most common finding on AECG
are ectopic heart beats: premature atrial complexes (PACs) and premature ventricular complexes
(PVCs) originating from the atrial and ventricular myocardium, respectively [8]. AECG allows for
quantification of PACs and PVCs, respectively called “PAC or PVC burden” wherein the number of
PACs or PVCs is expressed as a percentage of the total number of recorded heartbeats.
In order to be able to study the pathophysiological mechanisms underlying cardiovascular
disease, including cardiac rhythm disorders, in an in vivo context, experimental preclinical studies
have made extensive use of the mouse as a relevant animal model for human disease [9–12]. Several
techniques have already been described to obtain ECG data in mice [9,13]. These include standard
needle electrodes, platform ECG systems [14], tethered ECG systems [13,15] and telemetry [16].
Tethered ECG and telemetry best match the AECG in humans as they allow long-term monitoring in
conscious, freely-moving mice (Table 1) [13]. If the experimental design requires knowledge of the
spatial resolution (origin) of the ectopic beats, a tethered system is the best option as different lead
configurations can be assessed by implanting multiple electrodes.
Table 1. Characteristics of human ambulatory electrocardiography (AECG) and ECG techniques
available in mice.
Human
AECG
Mouse ECG
Needle
Electrodes
Platform ECG
System
Tethered ECG
System Telemetry
Conscious study subject + − + + +
Long-term analysis + − − + +
Unrestrained + − − +/− +
Spatial resolution ectopic
beat + + + + −
ECG: electrocardiography; AECG: ambulatory electrocardiography.
The application of the tethered ECG approach for use in mice has not been described in great
detail thus far, with only limited resources available in the literature [13]. Moreover, the assessment
of the origin of potential ectopic beats has not been evaluated before. In this paper we describe the
optimization of a protocol for the implementation of tethered ECG measurements in mice. We also
further highlight the application of automated algorithms which were developed to automatically
assess heart rate (HR), RR-interval, heart rate variability (HRV), and ectopic beats in the collected
ECG traces.
2. Materials and Methods
2.1. Mice
Four Male C57BL/6J mice of 10 weeks of age were used for this study. Housing conditions with a
controlled temperature (21 ◦C–22 ◦C) and relative humidity (40–60%) at a 12 h/12 h light/dark cycle
were used, with food and water available ad libitum. All animal procedures were approved by the
local ethical committee of Ghent University (ECD18/15) and were conducted in compliance with
directive 2010/63/EU.
2.2. Surgery and Instrumentation
Prior to surgery, mice were habituated to an in-house developed harness, which is used for the
fixation of the ECG electrode connector, for one week. In order to be able to put on the harness, mice
were briefly anesthetized (1.0–1.5% isoflurane, 0.5 L/min 100% O2). The harness consists of two parts:
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a corset made of stretchable cotton and a rigid platform made of Velcro (Figure 1). In the corset, two
holes were present for the front paws of the mouse. Two pairs of strings sewn to the lateral sides of the
corset were pulled through two pairs of holes on the lateral sides of the rigid platform, assuring that
this platform is fixed on the back of the mouse at the level of the mid-scapular region.
Figure 1. Schematic representation and picture of the in-house developed harness. (a,b) Corset piece
with cut-outs for the front paws and two pairs of strings attached to the lateral side. (c,d) Rigid platform
with central hole for the electrode leads and one hole at each corner for connection to the strings of the
corset. Black rectangle represents connector strip (female side exposed) with four insertion places for
each electrode lead.
After one week of habituation to the harness, mice underwent surgery for electrode lead
placement. Mice were anesthetized (induction at 5% isoflurane, 0.5 L/min 100% O2 and maintenance
at 1.0–1.5% isoflurane, 0.5 L/min 100% O2) and placed in a prone position on a heating pad set to
37 ◦C. The consciousness of the mice was checked by means of tail and foot pinch prior to surgery.
The harness was removed and approximately one cm2 of hair was shaved at the base level of the four
limbs and at the mid-scapular region. The bare skin patches were disinfected with a povidone–iodine
solution after which a 0.5 cm transverse incision was made uncovering the underlying muscle tissue.
Four insulated wire leads were used (AWG37, stainless steel PTFE coated wire; MEDwire, Sigmund
Cohn, Mount Vernon, NY, USA), of which approximately five mm of the insulation was removed
at the tip and subsequently curled up in order to increase the contact surface. The wire leads were
subcutaneously tunneled starting from the incision at the level of the limbs and exiting the body at the
level of the mid-scapular incision. After securing the leads to the underlying muscle tissue at the level
of the limbs all incisions were closed with silk suture (6-0, Fine Science Tools, Heidelberg, Germany)
and incision sites were treated topically with a neomycin/bacitracin anti-bacterial ointment. The exiting
ends of all electrode leads were pulled through a central hole in the rigid platform of the harness.
Approximately three mm of insulation was removed at the end of all electrode leads before placing
them in a Winslow-type connector strip (female side exposed) attached to the rigid platform of the
harness (Figure 1). After all electrode leads were placed in the connector strip, the leads were secured
by hot glue. Next, both front paws were pulled through the holes of the corset and the strings were
attached to the rigid platform. The mice were disconnected from the anesthesia device and 0.03 mg/kg
buprenorphine diluted in 0.5 mL saline solution (0.9%) was injected subcutaneously. Finally, mice
were placed in an empty cage with soft bedding under an infrared lamp until they were fully awake.
Animals were left for four days to recover from surgery.
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2.3. ECG Recording
After recovery, mice were slightly sedated with isoflurane before connection to the ECG set-up.
The connector strip on the rigid platform of the harness was connected to a 4-channel unity gain
preamplifier (based on a TL074 SMT Opamp, Texas Instruments, Dallas, TX, USA) by means of Winslow
connector pins (267-7400, RS components, Corby, UK). The preamplifier was attached to a swivel system
through a 6-channel commutator (Plastics One, Roanoke, VA, USA) allowing free movement of the
animal in the cage. Next, using a custom-made amplifier (based on TL074 Opamp, Texas Instruments),
the ECG signals were high-pass filtered at 0.15 Hz and amplified 512 times. The ECG signals were
digitized at a sampling rate of 2000 Hz (16-bit resolution, +/− 10 V input range) by means of a NiDAQ
card (USB-6259, National Instruments, Austin, TX, USA) with 32 analog input channels. For this study,
mice remained connected to the ECG set-up for four consecutive days. Three simultaneously recorded
ECG traces were obtained in lead I, II and III configurations (Figure 2). In this study, the ECG data
were subdivided into fragments of twenty minutes for the subsequent optimization and validation of
the analysis parameters. For analysis of long-term ECG recordings, we developed custom algorithms
that can be applied to multiple recorded fragments using a straightforward batch processing mode.
Figure 2. Mouse in supine position with schematic representation of the obtained lead configuration
(lead I, lead II and lead III) with representative ECG-traces. P-wave, QRS complex, and T-wave are
annotated on the ECG-trace in lead I configuration. Vertical and horizontal scale bars represent 1.5 mV
and 100 ms, respectively. G; ground, RFP; right front paw, LFP; left front paw, RHP; right hind paw,
LHP; left hind paw.
2.4. Pre-Processing ECG Trace
Lead II configuration resulted in the strongest signal and was therefore selected for further
analysis. We developed custom MATLAB® scripts, which are made available to the community
(https://github.com/tothmate9/ecg-analysis), to automate the processing as well as the qualitative and
quantitative analysis of the recorded data. Similar to human AECG recordings, pre-processing of the
obtained murine ECG data was performed in order to improve the signal quality (reduce baseline
wandering and increase signal-to-noise ratio) [17]. However, compared to the pre-processing of human
ECG data, an adapted filtering strategy needed to be applied due to the specific characteristics of the
obtained murine electrophysiological signal [12] (Figure 3). A first pre-processing step, a zero-phase
high-pass filter (HPF), was applied to increase the signal-to-noise ratio [18]. Therefore, a second
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order Butterworth filter with cut-off frequency of 5 Hz was applied, filtering out respiratory activity
and muscle activity [19,20]. After the high-pass filtering, the signal was down-sampled in order to
reduce the computational and data storage load for analysis of long data recordings. The optimal
down-sampling ratio was determined to retain a maximal amount of information. Next, Fast Fourier
Transformation (FFT) was applied in order to increase the signal-to-noise ratio. By means of FFT, the
temporal information of the ECG signal is converted into frequency information. A band-pass filter
was applied to identify the frequency of the QRS complex and to eliminate the motion artefacts and
the baseline wander. For a sample rate of 1000 Hz, the cut-off frequencies were set to 100 and 200 Hz.
After band-pass filtering the ECG signal is again converted into standard temporal information by
means of inversed FFT [21–23]. Next, a zero-phase derivative filter was applied to further increase
the signal-to-noise ratio. In contrast to conventional noise reducing filters, the zero-phase filtering
does not create a phase shift, hence preserving the temporal resolution of the QRS complex [24,25].
The derivative filter produced a suitable input for subsequent R-peak detection.
Figure 3. Schematic representation of the different pre-processing steps applied to the input file and
resulting effect on the ECG trace. FFT; Fast Fourier Transformation.
2.5. ECG Parameter Extraction
First, R-peak detection was performed on the pre-processed signal based on a minimum peak
distance and peak height which were determined empirically (default thresholds are 50 ms and
0.05 mV, respectively). The detected R-peaks were displayed on the band-pass filtered ECG-trace.
The sensitivity (Equation (1)), precision (Equation (2)) and specificity (Equation (3)) of the R-peak
detection of the developed script were compared to the open access platform PhysioZoo which was
developed to analyze ECG recordings from humans as well as different mammalian species, including
mice [26]. On selected previously analyzed 20-min ECG traces, all R-peaks were manually annotated
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and considered as reference values needed to calculate the number of true positive, true negative, false
positive and false negative peaks detected by the algorithm.
Sensitivity = # true positive/(# true positive + # false negative), (1)
Precision = # true positive/(# true positive + # false positive), (2)
Specificity = # true negative/(# true negative + # false positive), (3)
Next, the different ECG parameters, including average HR, mean RR-interval and HRV, were
automatically calculated based on the detected R-peaks. The average HR was computed as the total
amount of detected R-peaks on the pre-processed ECG signal divided by the recording time. For the
mean RR-interval, the distance in time (ms) between two consecutive R-peaks was determined for all
detected R-peaks in the analyzed ECG trace, after which the mean was automatically calculated.
Finally, the RR-intervals detected in the analyzed ECG trace were used for the evaluation of HRV.
A histogram was plotted based on the frequency of discrete RR-interval ranges within the analyzed
ECG trace. The x-axis represents the observed RR-intervals (within intervals of 1 ms), while the
y-axis represents the frequency of the respective RR-interval range. The width of the histogram of all
RR-interval ranges at the level of half of the maximum counted prevalence is used as a representative
value for HRV, indicated with FWHM (Full-Width at Half-Maximum). This measure provides a read-out
regarding the distribution of the normal RR-intervals with larger values indicating a wider heart rate
variability. Interference by aberrant RR-intervals due to incorrect R-peak detection and ectopic beats is
not included in this method of HRV measurement as the prevalence of their time-intervals is negligible
and is most-likely located at the tails of the histogram.
2.6. Ectopic Beat Detection
Arrhythmic events were identified semi-automatically based on deviating RR-intervals.
We identified the ectopic beats by applying a moving average filter with a 100 RR-interval sliding
window, which was empirically determined to provide the best performance. This filter operates on
the RR-intervals and marks the detected R-peaks which differ, based on a given threshold, from the
moving average as ectopic beats. This threshold is arbitrary and can be manually changed in the
script. For this study we used a threshold of 30% as this value is small enough to trigger ectopic beat
identification without detection of intervals within the range of normal variability in sinus rhythm [27].
The detected potential ectopic beats were saved as a separate output file for further manual evaluation.
In order to assess the type of ectopic beat (for example, PAC versus PVC), manual evaluation of the
ECG traces was performed on the unfiltered ECG trace at 2000 Hz. Furthermore, an estimation of the
origin of the ectopic beat within the heart was evaluated using all three lead configurations obtained
from the different electrode leads.
2.7. Statistics
Statistical analysis was performed with the statistical software package SPSS (version 25.0).
The comparison of the sensitivity, precision and specificity of the R-peak detection between the custom
MATLAB® script and the open access platform PhysioZoo was performed by means of a paired
samples test. Correlation analysis between the number of false positive ectopic beat detections and the
quality of the ECG trace was performed by implementation of a parametrical Pearson correlation test.
A p-value < 0.05 was defined as statistically significant (two-sided).
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3. Results
3.1. ECG Recording
During data collection, the harness proved to be stable and allowed for reliable recordings while
mice (n = 4) were able to move around in their cage without disconnecting from the ECG set-up.
Four days after initial connection to the ECG set-up, the data were collected and analyzed offline.
Murine ECG traces were obtained using lead I, II and III configurations (Figure 2). On the obtained
traces the different deflections, including the P-wave, the QRS-complex, and the T-wave could be
distinguished (Figure 2). To evaluate the quality of the ECG trace, time segments on which individual
R-peaks could not be manually distinguished were added up and divided by twenty minutes in order
to get a percentage. Overall, an average of 0.95% (SE 0.47%) of the traces were of bad quality most
likely due to excessive movement of the animal (n = 10 ECG traces of twenty minutes).
3.2. ECG Parameter Extraction
The sensitivity, precision and specificity of the R-peak detection by our custom automated
algorithms were evaluated for ten ECG fragments of twenty minutes randomly selected from four
mice after down-sampling the recorded data to 1000 Hz. For this analysis the ECG data obtained from
lead II configuration was selected as this trace represented the strongest signal. The obtained values
were compared with the output obtained from the PhysioZoo ECG software. No significant difference
could be observed in sensitivity, specificity or precision between both methods (Table 2, paired samples
test, p ≥ 0.144), validating the performance of our novel algorithms. The subsequent calculations of
the different ECG-parameters, including average HR, mean RR-interval and HRV, highly depend on
this R-peak detection. These values are automatically calculated and presented after analysis of the
recorded ECG data by our custom MATLAB® scripts (Figure 4).
Table 2. Sensitivity, precision and specificity of R-peak detection compared between our automated
custom algorithms and PhysioZoo (n = 10 ECG traces of twenty minutes).
File TP TN FP FN Sensitivity Precision Specificity
CUSTOM
ALGORITHMS
001 11780 1188216 2 2 0.999830 0.999830 0.999998
002 12413 1187556 16 15 0.998793 0.998713 0.999987
003 11274 1188723 1 2 0.999823 0.999911 0.999999
004 11209 1188758 18 15 0.998664 0.998397 0.999985
005 10524 1189468 4 4 0.999620 0.999620 0.999997
006 11580 1188405 8 7 0.999396 0.999310 0.999993
007 10794 1189197 2 7 0.999352 0.999815 0.999998
008 11085 1188871 25 19 0.998289 0.997750 0.999979
009 13366 1186524 56 54 0.995976 0.995828 0.999953
010 13411 1186489 45 55 0.995916 0.996656 0.999962
Mean values 0.998566 0.998583 0.999985
PhysioZoo
001 11773 1188209 11 9 0.999236 0.999067 0.999991
002 12417 1188484 3 11 0.999115 0.999758 0.999997
003 11270 1187595 6 6 0.999468 0.999468 0.999995
004 11222 1188730 3 2 0.999822 0.999733 0.999997
005 10521 1189491 9 7 0.999335 0.999145 0.999992
006 11574 1188412 7 13 0.998878 0.999396 0.999994
007 10785 1189199 11 16 0.998519 0.998981 0.999991
008 11072 1188864 29 32 0.997118 0.997388 0.999976
009 13348 1186497 73 72 0.994635 0.994561 0.999938
010 13410 1186419 53 56 0.995841 0.996063 0.999955
Mean values 0.998197 0.998356 0.999983
p-values 0.144 0.408 0.360
TP: true positive; TN: true negative; FP: false positive; FN; false negative.
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Figure 4. Graphical user interface presentation of the automatically calculated ECG parameters
after running the custom MATLAB® scripts on a representative twenty-minute murine ECG trace.
(a) Detected R-peaks are visualized with blue dots on the (compressed) murine ECG trace. Total amount
of detected R-peaks and calculated heart rate is presented in the title of the graph. (b) Histogram
representing the distribution of the observed RR-intervals. X-values are subdivided in intervals of 1 ms.
Automated calculation of the mean RR-interval and Full-Width at Half-Maximum (representative for
heart rate variability) is presented in the title of the graph. The level of the Full-Width at Half-Maximum
value is visualized by means of a red line within the graph. ECG; electrocardiogram, BPM; beats per
minute, FWHM; Full-Width at Half-Maximum.
Similar measurements of sensitivity, precision and specificity were performed on an ECG recording
at different sample rates (2000, 1000, 500, 400 and 250 Hz) in order to evaluate the ideal balance between
a maximal reduction in computational load due to data down-sampling while achieving minimal
loss of performance for long-term measurements (more than twenty minutes). For this optimization
an ECG file with a high-quality signal was used (with only 0.03% of the ECG trace marked as bad
quality). We found that the sensitivity of the R-peak detection was dependent on the sample rate of
the ECG file (Figure 5), declining significantly with sample rates < 400 Hz. Based on this comparison,
for automatic analysis of long-term ECG recordings down-sampling to frequencies below 400 Hz is
not recommended.
Figure 5. Sensitivity, precision and specificity of R-peak detection of the same ECG file at different
sample rates analyzed with our custom algorithms.
3.3. Ectopic Beat Detection
Analysis of potential ectopic beats was performed on eight twenty-minute ECG traces in lead II
configuration. Sample rates of 1000 Hz were used to diminish computational load while preserving
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high-quality data as ectopic beat detection is based on aberrant RR-intervals. A high sensitivity of
R-peak detection is thus warranted as this will lead to less false positive ectopic beat detections. After
running the script, potential ectopic beats are visualized as regions of interest (ROI) in a separate
output file (pdf format). These pdf files can then be manually checked for the presence and nature
of an ectopic beat (Figure 6a). As expected, false positive recordings were also found (Figure 6b).
The number of false positive detections significantly correlated with the quality of the ECG trace as
determined by the percentage of bad quality tracing (Pearson correlation = 0.731, p = 0.039). On the
other hand, the number of detected true ectopic beats does not correlate with the quality of the ECG
trace (Pearson correlation = 0.172, p = 0.685).
Figure 6. Ectopic beat detection. (a) Representative output obtained for ectopic beat detection showing
the aberrant RR-interval. Detected R-peaks are indicated with blue dots on the band-pass filtered
ECG-trace. (b) Correlation analysis between the percentage of bad quality of the ECG trace and false
positive and true positive ectopic beat detection (n = 8 ECG traces of twenty minutes). The number of
false positive and true positive ectopic beats are depicted with a grey x and a black +, respectively. ROI;
Region of interest.
In order to analyze the type and estimate the origin of the observed ectopic beats, the ECG recording
of the respective beats at 2000 Hz must be used (unfiltered ECG data). Using these high-resolution
tracings, the P-waves can also be discerned, which are more difficult to distinguish from background
noise when lower sample rates are used. The identification of P-waves can be useful in the evaluation
of the type of ectopic beat. Distinction between a blocked P-wave and sinus arrest can only be made
based on the presence or absence of a P-wave before a missing QRS-complex, respectively (Figure 7).
In the former, a P wave is present without a subsequent QRS-complex, whereas in the latter a P-wave
is absent. The probable spatial origin of an observed ectopic beat can be determined depending on
the orientation and magnitude of the extra QRS complex in the three obtained lead configurations.
Representative examples are presented in Figure 8.
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Figure 7. P-wave analysis on representative mouse ECG files at a sample rate of 2000 Hz. (a) Blocked
P-wave based on the presence of a P-wave (indicated with arrow) without subsequent QRS-complex.
(b) Sinus arrest based on the absence of an extra P-wave in between a long RR-interval. Vertical and
horizontal scale bars represent 0.5 mV and 100 ms, respectively. Hashtag indicates absence of p-wave
indicating sinus arrest.
Figure 8. Representative ectopic beats recorded in mice using lead I, II and III configurations. (a) An
ectopic beat with either an atrial or junctional origin, based on a narrow QRS complex; (b,c) ectopic
beats with origin in the ventricles (based on a broad QRS complex); for (b) an inferior axis and for (c) a
superior axis can be inferred based on the ECG pattern. Vertical and horizontal scale bars represent 1
mV and 100 ms, respectively. Ectopic beats are indicated with asterisks.
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4. Discussion
AECG is a powerful diagnostic tool to study cardiac arrhythmia. This is mainly due to its ability to
analyze long-term ECG data, which is associated with an improved diagnostic yield [5]. Mice have been
widely used as a model system in cardiovascular research mainly because their genome can be easily
altered and because there is a strong resemblance to basic human physiology [9]. To investigate cardiac
arrhythmia, tethered ECG set-ups allow long-term ECG recordings in conscious, freely moving mice,
similar to AECG in humans. In this paper we provided a detailed description of the surgical technique
and the instrumentation necessary for a tethered ECG set-up in mice. Furthermore, automated
scripts were developed, optimized, and validated for analysis of the obtained ECG data and ectopic
beat detection.
The surgical implantation of the electrode leads was similar to a previously published protocol [13],
with several important improvements. A custom-made, two-piece harness was made to accommodate
the ECG connection to the tether. The customizable, snug fit assured that the harness stays in place
during recordings without hampering normal movement or breathing of the mouse. Furthermore, the
harness can easily be connected and disconnected to the tether when needed. During recording, no
detachment of the electrode leads nor harness was observed in all four included mice for this study.
However, as recording periods were limited to four days for this study, the durability of the tethered
setup needs to be tested for longer recording periods.
Our tethered ECG set-up was able to generate high-fidelity ECG traces in lead I, II and III
configurations. The different murine ECG traces could be visualized and the R-peak could be visually
distinguished from the background noise in more than 99% of the ECG traces. ECG segments of bad
quality were most likely caused by movement artefacts which are also observed in human AECG
recordings [5]. Movement artefacts are considered as an inherent disadvantage of AECG. However,
the benefits of AECG recording transcend this disadvantage as certain types of arrhythmia may be
transient and can thus only be detected with AECG [5].
As a large amount of data can be obtained with this tethered ECG set-up, automated analysis
of the ECG data is necessary for efficient and unbiased data extraction. For this reason, custom
MATLAB® scripts were developed. Parameters used for data filtration were optimized, enabling a
robust signal-to-noise ratio for efficient automated R-peak detection. Data sample rates were adjusted
to find an ideal balance between signal quality and reduced computing load for the analysis of
long-term recordings. We were able to confirm that our algorithms have a similar efficiency of R-peak
detection compared to PhysioZoo [26], an online available ECG analysis software program specifically
tailored to processing ECG recordings from different species including mice. Furthermore, based on
this R-peak detection, important ECG parameters including the average HR, the mean RR-interval
and HRV were automatically calculated after running the custom MATLAB® scripts on the ECG data.
Though these parameters can also be calculated by implementation of the PhysioZoo software, the
PhysioZoo software mainly focuses on HRV analysis. For this reason, the pre-filtering of the ECG
data in PhysioZoo removes ectopic beats as these interfere with the HRV analysis [26]. This specific
pre-filtering step thus hampers subsequent ectopic beat detection which is not the case with our custom
scripts. In order to still provide a measure of HRV when using our algorithms, we have included the
FWHM measurement of the RR-interval histogram.
Ectopic beat detection relies on sensitive and accurate R-peak detection. Aberrant RR-intervals
based on a deviation of the moving average were identified as ROI for ectopic beats. Using this
automated annotation of specific ROI’s large amounts of ECG data can be analyzed quickly for the
presence of ectopic beats. The quantification of ectopic beats is of interest as several studies have
demonstrated an association between high PAC burden and arrhythmias such as atrial fibrillation,
atrial flutter and supraventricular tachycardia [28,29]. Likewise, a high PVC burden may be associated
with reduced left ventricular ejection fraction, PVC-induced cardiomyopathy and increased risk of
sudden cardiac death [30,31].
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A unique advantage of the tethered ECG method described in this paper is that multiple lead
configurations can be obtained: lead I, II and III. In the absence of abnormal heart orientation, multiple
lead configurations allow, to a certain extent, the estimation of the spatial origin of the observed ectopic
beat. The knowledge of the origin of an ectopic beat might benefit the search for the underlying
disease mechanism in mouse models developing arrhythmia (e.g., myocardial infarction). Furthermore,
the assessment of multiple lead configurations can be beneficial to validate the presence of abnormal
ECG patterns observed in a single lead. As a future extension, based on these lead configurations the
augmented lead configurations (aVR, aVL and aVF) can be calculated. Combined with the lead I, II
and III configurations, these augmented leads will give more detailed information about the ECG in
the frontal plane of the heart.
5. Conclusions
Overall, the described tethered ECG protocol allows long-term recording of high-quality ECG
traces in conscious, freely moving mice. Furthermore, automated algorithms are provided for efficient
HR, RR-interval and HRV analysis and ectopic beat detection. This technique can be readily applied
for the characterization of existing and new mouse models with potential arrhythmic disorders.
Furthermore, this set-up can be used to test the effects of anti-arrhythmic drugs as well as to assess
cardiovascular safety of novel drugs which could potentially be translated to the clinic.
6. Limitations
Using the current script, stretches of bad quality data within the input ECG data are not
automatically excluded for subsequent HR analysis. Consequently, the calculated HR will slightly
differ from the true HR. However, due to prior extensive pre-processing of the ECG signal, the
percentage of bad quality stretches is limited and will only have a negligible effect on the calculation
of the HR. Furthermore, we were unable to prove the ability of the developed script to detect more
complex patterns of activation than PVC and PAC, as these events are rarely found in mice [12] and
did not occur in the wild-type mice used in our study.
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